HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica Robinson-Papp Selected Research

Jessica Robinson-Papp Research Topics

Disease

10Chronic Pain
01/2022 - 10/2012
9Pain (Aches)
01/2022 - 09/2015
4Polyneuropathies (Polyneuropathy)
01/2022 - 08/2009
4Neuralgia (Stump Neuralgia)
01/2022 - 09/2007
3Mental Disorders (Mental Disorder)
01/2022 - 10/2012
3Cognitive Dysfunction
01/2022 - 08/2008
3HIV Infections (HIV Infection)
01/2022 - 08/2009
3Inflammation (Inflammations)
08/2020 - 01/2018
2Disease Progression
02/2022 - 01/2018
2Hypertension (High Blood Pressure)
01/2022 - 04/2013
2Acquired Immunodeficiency Syndrome (AIDS)
04/2017 - 08/2009
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Fever (Fevers)
01/2022
1Mood Disorders (Mood Disorder)
01/2022
1Chronic Renal Insufficiency
01/2022
1Infections
10/2020
1COVID-19
10/2020
1Spinal Cord Diseases
02/2018
1Neurocognitive Disorders (Clerambault Syndrome)
01/2018
1Peripheral Nervous System Diseases (PNS Diseases)
01/2017
1Inborn Genetic Diseases (Disease, Hereditary)
12/2013
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
12/2013
1Leukoencephalopathies
09/2013
1Central Nervous System Diseases (CNS Diseases)
04/2013
1Substance-Related Disorders (Drug Abuse)
10/2012
1Dementia (Dementias)
08/2008
1Neurologic Manifestations (Neurological Manifestations)
08/2008

Drug/Important Bio-Agent (IBA)

8Opioid Analgesics (Opioids)IBA
01/2022 - 10/2012
26-chloropenicillanic acid S-sulfoxideIBA
01/2022 - 04/2013
2Analgesics (Analgesic Drugs)IBA
09/2015 - 09/2013
1Adrenergic Receptors (Adrenergic Receptor)IBA
02/2022
1methylglyoxal bis(3-aminopropylamidinohydrazone)IBA
01/2022
1Amitriptyline (Elavil)FDA LinkGeneric
01/2022
1Antinuclear AntibodiesIBA
01/2022
1AutoantibodiesIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Glutamic Acid (Glutamate)FDA Link
01/2022
1Pharmaceutical PreparationsIBA
11/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1Interleukin-6 (Interleukin 6)IBA
08/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
08/2020
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
01/2019
1Lipopolysaccharide ReceptorsIBA
01/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
02/2018
1OligonucleotidesIBA
11/2017
1Capsaicin (Zostrix)FDA Link
01/2017
1Amyloid (Amyloid Fibrils)IBA
12/2013
1Diflunisal (Dolobid)FDA Link
12/2013
1Prealbumin (Transthyretin)IBA
12/2013
1Antidepressive Agents (Antidepressants)IBA
09/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2013
14-dichlorobenzene (1,4-dichlorobenzene)IBA
09/2013
1Cholinergic Antagonists (Anticholinergics)IBA
04/2013
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
04/2013
1Duloxetine Hydrochloride (Cymbalta)FDA Link
09/2007
1Pregabalin (Lyrica)FDA Link
09/2007

Therapy/Procedure

8Therapeutics
01/2022 - 04/2017
5Pain Management
01/2022 - 09/2015
4Highly Active Antiretroviral Therapy (HAART)
04/2015 - 08/2008
1Inappropriate Prescribing
01/2022
1Molecular Targeted Therapy
01/2022
1Activities of Daily Living (ADL)
01/2016